These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17981234)

  • 1. Hepatitis B and end-stage liver disease.
    Weisberg IS; Brown RS; Sigal SH
    Clin Liver Dis; 2007 Nov; 11(4):893-916, ix. PubMed ID: 17981234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF
    Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus infection and liver transplantation.
    Kennedy M; Alexopoulos SP
    Curr Opin Organ Transplant; 2010 Jun; 15(3):310-5. PubMed ID: 20445447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report. Hepatitis B virus and HIV coinfection.
    Piliero PJ; Faragon JJ
    AIDS Read; 2002 Oct; 12(10):443-4, 448-51. PubMed ID: 12408101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End points of therapy in chronic hepatitis B.
    Ahmed SN; Ecochard M; Zoulim F
    Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):37-49. PubMed ID: 20136588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection.
    McGovern BH
    Antivir Ther; 2007; 12 Suppl 3():H3-13. PubMed ID: 18284178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.
    Brown A; Goodman Z
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):187-98. PubMed ID: 22375524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir].
    Dumortier J; Durupt S; Chevallier M; Trépo C; Zoulim F
    Gastroenterol Clin Biol; 1997; 21(12):982-6. PubMed ID: 9587563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halting the natural history of hepatitis B viral infection: a paradigm shift.
    Perrillo RP; Jacobson IM
    Semin Liver Dis; 2007 Aug; 27 Suppl 1():3-8. PubMed ID: 17701844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis].
    Merle P; Zoulim F; Vitvitski L; Trépo C
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1166-76. PubMed ID: 11173729
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.
    Perrillo R
    J Am Acad Nurse Pract; 2006 May; 18(5):203-15. PubMed ID: 16681707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, diagnostic tests and monitoring of hepatitis B virus in monoinfected and HIV-coinfected patients.
    Thio CL
    Antivir Ther; 2007; 12 Suppl 3():H25-31. PubMed ID: 18284180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.